CPSC Extends Stay of Enforcement on Child-Resistant Packaging for Imidazolines

The Consumer Product Safety Commission is giving some companies another six months to comply with a final rule requiring child-resistant packaging on pharmaceuticals containing imidazolines (here). When it issued its final rule in December 2012, CPSC had given drug companies a year to comply and an additional one-year stay of enforcement, if requested. With the stay set to expire on Dec. 10, several companies told CPSC they still aren’t in a position to comply, said the agency. CPSC is now extending until June 10 the compliance date. Only companies that originally requested the stay in enforcement are eligible for the extension.